National Medical Insurance Administration: Key drug "deferoxamine" for treating "thalassemia" included in medical insurance.

Starting from January 1st, 2026, the country's new version of the medical insurance drug list will be fully implemented in Guangxi. In this adjustment of the list, the National Medical Insurance Administration has negotiated to include "Deferoxamine tablets" in the national medical insurance drug list, effectively meeting the medical needs of patients with Mediterranean anemia, and reducing the medication burden on insured patients' families.